Porous cementless cups combined with trabecular metal augments in revision hip arthroplasty: mid-term outcomes

多孔无骨水泥髋臼杯联合骨小梁金属增强物在翻修髋关节置换术中的应用:中期结果

阅读:2

Abstract

Reconstruction of acetabular bone defects represents one of the most technically demanding aspects of revision total hip arthroplasty. Although numerous implant options and surgical techniques have been proposed, porous acetabular components combined with trabecular metal augments have gained widespread acceptance as a contemporary reconstructive strategy. The present study aims to assess implant survivorship and to report mid-term clinical and radiographic outcomes associated with this technique. We identified 69 revision total hip arthroplasties (69 patients) performed at the Department of Joint Arthroplasty of the Priorov National Medical Research Center of Traumatology and Orthopedics between January 2016 and June 2022, using porous acetabular cups in combination with trabecular metal augments. Among these patients, 46 (66.6%) were female and 23 (33.4%) were male. The mean patient age was 59.9 years (± 12.4), with a mean follow-up duration of 4.9 years (± 1.78), ranging from a minimum of 2.6 years to a maximum of 9 years. Functional outcomes were assessed using the Harris Hip Score (HHS), Visual Analogue Scale (VAS), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), while implant survival was evaluated using Kaplan-Meier analysis. The overall HHS significantly improved from a preoperative mean of 32.9 (± 9.8) to a postoperative mean of 86.7 (± 4.9). VAS scores decreased from 8.1 (± 0.5) to 3.4 (± 0.5), WOMAC scores decreased from 61.3 (± 4.7) to 24.7 (± 2.4), indicating favorable clinical and functional outcomes (p < 0.00001 for each scale). Kaplan-Meier survival analysis demonstrated a 9 years (109.7 months) cumulative implant survivorship rate of 98.55%. The results indicate that porous acetabular cups combined with trabecular metal augments represent an effective option in revision hip arthroplasty, demonstrating excellent mid-term outcomes in terms of both implant survivorship and functional improvement.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。